Table 3. Haplotype distribution of the control and POAG and PCAG patients.
| |
Frequency |
|
|
Frequency |
|
|
|
|---|---|---|---|---|---|---|---|
| Haplotypes | control | POAG | p | OR [95% CI] | PCAG | p | OR (95% CI) |
|
Block 1 (rs3793342-rs11771443) | |||||||
| C-C |
0.486 |
0.423 |
0.184 |
0.775 [0.532~1.129] |
0.484 |
0.970 |
0.993 [0.673~1.465] |
| C-T |
0.018 |
0.087 |
<0.001 |
5.111 [1.766~14.788] |
0.033 |
0.337 |
1.834 [0.523~6.434] |
| T-C |
0.389 |
0.371 |
0.699 |
0.927 [0.631~1.362] |
0.346 |
0.363 |
0.829 [0.553~1.242] |
| T-T |
0.107 |
0.119 |
0.683 |
1.130 [0.627~2.038] |
0.137 |
0.341 |
1.334 [0.737~2.414] |
|
Block 2 (rs743507- rs7830) | |||||||
| A-A |
0.292 |
0.292 |
0.999 |
1.000 [0.663~1.507] |
0.302 |
0.756 |
1.070 [0.698~1.640] |
| A-C |
0.541 |
0.531 |
0.837 |
0.962 [0.661~1.398] |
0.539 |
0.904 |
1.025 [0.691~1.520] |
| G-A |
0.158 |
0.139 |
0.584 |
0.863 [0.510~1.462] |
0.136 |
0.571 |
0.852 [0.489~1.484] |
| G-C | 0.009 | 0.037 | 0.041 | 4.331 [0.935~20.072] | 0.023 | - | - |